Stockscreener 앱 받기
1.05
0.94%
-0.01
시간 외 거래:
1.06
0.01
+0.95%
전일 마감가:
$1.06
열려 있는:
$1.05
하루 거래량:
329.33K
Relative Volume:
1.50
시가총액:
$61.82M
수익:
-
순이익/손실:
$-51.47M
주가수익비율:
-1.05
EPS:
-1
순현금흐름:
$-47.50M
1주 성능:
-9.48%
1개월 성능:
+19.56%
6개월 성능:
-30.46%
1년 성능:
-33.54%
1일 변동 폭
$0.9642
$1.07
1주일 범위
$0.9642
$1.18
52주 변동 폭
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
명칭
Pmv Pharmaceuticals Inc
전화
(609) 642-6670
주소
400 ALEXANDER PARK DRIVE, PRINCETON
PMVP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.05 | 61.82M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2024-05-13 | 개시 | Craig Hallum | Buy |
| 2024-04-12 | 개시 | Jefferies | Buy |
| 2023-12-27 | 개시 | Ladenburg Thalmann | Buy |
| 2022-03-02 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-22 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-08-19 | 개시 | Oppenheimer | Perform |
| 2021-08-02 | 개시 | Guggenheim | Buy |
| 2021-07-29 | 개시 | H.C. Wainwright | Buy |
| 2020-10-20 | 개시 | BofA Securities | Buy |
| 2020-10-20 | 개시 | Cowen | Outperform |
| 2020-10-20 | 개시 | Evercore ISI | Outperform |
| 2020-10-20 | 개시 | Goldman | Neutral |
모두보기
Pmv Pharmaceuticals Inc 주식(PMVP)의 최신 뉴스
Millennium Management LLC Has $480,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stake in indie Semiconductor, Inc. (NASDAQ:INDI) - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 12,462 Shares of Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) - Defense World
Squarepoint Ops LLC Increases Stake in Westwater Resources, Inc. (NASDAQ:WWR) - Defense World
Squarepoint Ops LLC Acquires 29,722 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
G-III Apparel Group (NASDAQ:GIII) Price Target Lowered to $18.00 at Barclays - Defense World
Blue Bird Co. (NASDAQ:BLBD) Shares Sold by California State Teachers Retirement System - Defense World
pmv pharmaceuticals holds virtual annual meeting, elects directors By Investing.com - Investing.com South Africa
pmv pharmaceuticals holds virtual annual meeting, elects directors - Investing.com
PMV Pharmaceuticals Holds 2025 Annual Stockholder Meeting - TipRanks
Jane Street Group LLC Has $75,000 Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Two Sigma Investments LP Buys 23,931 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
GAMMA Investing LLC Has $11.48 Million Stake in News Co. (NASDAQ:NWS) - Defense World
Ameriprise Financial Inc. Sells 16,715 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Bank of America Corp DE Has $932,000 Stake in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) - Defense World
Citadel Advisors LLC Purchases New Position in Invesco S&P SmallCap Consumer Staples ETF (NASDAQ:PSCC) - Defense World
Water Technologies International (OTCMKTS:WTII) Shares Pass Above 200-Day Moving Average – Here’s What Happened - Defense World
First Trust North American Energy Infrastructure Fund (NYSEARCA:EMLP) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World
Halma (LON:HLMA) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Saputo (TSE:SAP) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Persimmon (LON:PSN) Stock Passes Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Solstice Gold (CVE:SGC) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened - Defense World
Bowl America (NYSEAMERICAN:BWL.A) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Northern Trust Corp Has $162,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Pre-market Movers: LYRA, INM, OGEN, VERA... - RTTNews
Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - The Manila Times
PMV Pharmaceuticals to Participate at Upcoming Investor Conferen - GuruFocus
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences | PMVP Stock News - GuruFocus
PMV Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences on Oncology Innovation and Healthcare Advances - Nasdaq
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences - GlobeNewswire
PMV Pharma CEO Reveals Latest Oncology Innovation Strategy at Two Major Healthcare Conferences - Stock Titan
D. E. Shaw & Co. Inc. Sells 16,189 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Gotham Asset Management LLC Sells 176,437 Shares of Gain Therapeutics, Inc. (NASDAQ:GANX) - Defense World
These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe - The Globe and Mail
We're Keeping An Eye On PMV Pharmaceuticals' (NASDAQ:PMVP) Cash Burn Rate - Yahoo Finance
Crude Prices Rise on Doubts About a US-Iran Nuclear Deal - The Globe and Mail
Is Enbridge Stock Still Worth Owning After Strong Q1 Earnings? - The Globe and Mail
PMVP Advances PYNNACLE Trial with Steady Enrollment | PMVP Stock News - GuruFocus
PMV Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights | PMVP Stock News - GuruFocus
PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
PMV Pharmaceuticals Reports First Quarter 2025 Financial Results and Corporate Highlights - GlobeNewswire
PMVP Reports First Quarter Cash Position and Operational Spendin - GuruFocus
Randy A. Bowman Appointed Chairman of the Board at Westwood Holdings Group - The Manila Times
PMV Pharmaceuticals Reports Progress in Phase 2 PYNNACLE Trial and First Quarter 2025 Financial Results - Nasdaq
JPMorgan Chase & Co. Buys 23,559 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
In the Green: PMV Pharmaceuticals Inc (PMVP) Closes at 0.87, Up/Down -7.34 from Previous Day - DWinneX
I Update My Buy Recommendation for Reddit Stock - The Globe and Mail
PMV Pharmaceuticals Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
Nutshell gains IND clearance for p53 Y220C reactivator NTS-071 - BioWorld MedTech
Pmv Pharmaceuticals Inc (PMVP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pmv Pharmaceuticals Inc 주식 (PMVP) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
| Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.39%
0.42%
자본화:
|
볼륨(24시간):